We describe a noninvasive, quantitative, and tomographic method to visualize lymphocytes within the whole animal. We used positron-emission tomography (PET) to follow the localization of adoptively transferred immune T lymphocytes. Splenic T cells from animals that had rejected a Moloney murine sarcoma virus͞ Moloney murine leukemia virus (M-MSV͞M-MuLV)-induced tumor were marked with a PET reporter gene, injected into tumor-bearing mice, and imaged in a microPET by using a substrate specific for the reporter. Specific localization of immune T cells to the antigenpositive tumor was detected over time, by sequential imaging of the same animals. Naive T cells did not localize to the tumor site, indicating that preimmunization was required. Autoradiography and immunohistochemistry analysis corroborated the microPET data. The method we have developed can be used to assess the effects of immunomodulatory agents intended to potentiate the immune response to cancer, and can also be useful for the study of other cell-mediated immune responses, including autoimmunity.
F]FDG), which detects glucose metabolic activity, is used in clinical practice to assess the location(s) of tumors for diagnosis, presurgical staging, and monitoring for recurrence or response to various treatments (5) . The development of a microPET scanner (6) enables this technology to be used with small animals such as the mouse. The cells of interest are marked with a PET reporter gene, injected into a test subject, and imaged by injection of the animals with radiolabeled substrates specific for expression of the reporter gene. Repeated imaging of the same animals provides kinetic quantitative information on cell migration, localization and expansion.
We assessed whether microPET imaging technology could be used to follow the specific localization and expansion of adoptively transferred immune T lymphocytes to the antigen-positive tumor and other sites within the animal. We used a well-characterized virally induced sarcoma tumor model (7) . One hundred percent of BALB͞c or C57BL͞6 mice challenged with the Moloney murine sarcoma virus (M-MSV)͞Moloney murine leukemia virus (M-MuLV) reject the tumor (8, 9) . Rejection is mediated by CD8 ϩ cytolytic T cells, which recognize peptides from the gag and env proteins of M-MuLV (8, 10) , and it is more efficient in the presence of CD4 ϩ T cells (11) . Splenic T lymphocytes were transduced with the HSV1-sr39TK PET reporter gene (HSV1, herpes simplex virus 1; TK, thymidine kinase) (12) and transferred into immunodeficient tumor-bearing mice. Tumor-bearing animals were imaged with microPET several times after T cell injection, visualizing marked T cells by using 9-[4-[ (13) , a radioactive substrate for sr39TK. We established that transferred immune T cells localized to the tumor, whereas naive T cells were not detected at the tumor site.
The key elements of this method, developed in rodents, are the ability to label cells of interest ex vivo with a reporter gene, reintroduce them into the living animal, and subsequently follow their movement in vivo by a sensitive, noninvasive, quantitative tomographic imaging system. Construction of Plasmids. The 1.0-kb sr39TK fragment was released by EcoRI digestion from the PET23a(ϩ):TK vector and cloned into the promoter-proximal EcoRI site of MSCV-IRES-GFP (MSCV, murine stem cell virus; IRES, internal ribosomal entry site).
Materials and Methods
Generation of Virus Stocks. M-MSV͞M-MuLV stock was isolated from viable M-MSV͞M-MuLV-induced tumors generated in irradiated C57BL͞6 mice. The ecotropic retrovirus MSCV-sr39TK-IRES-GFP was generated by transient transfection of HEK-293T cells. Fresh viral supernatant was used for infection of T lymphocytes.
Generation of Immune and Tumor-Bearing Mice. Five-to 10-week-old female BALB͞c and CB.17 SCID/SCID mice were challenged intramuscularly in the left forelimb with M-MSV͞M-MuLV in 100 l. control P815 tumor cells were injected s.c. near the right shoulder either in the same animal or in separate animals. Tumor growth was monitored by caliper measurements every 3-4 days. Animals were killed when they were moribund or the tumor had reached a volume of 1.5 cm Purification and Retroviral Infection of T Lymphocytes. Mouse splenocytes were depleted of B cells by using anti-(␣)-B220-coated magnetic beads (Dynal, Great Neck, NY). T cell purity (Ͼ90%) was determined by staining with ␣-B220, ␣-CD8, and ␣-CD4 C-labeled 1-(2Ј-deoxy-2Ј-fluoro-␤-D-arabinofuranosyl)-5-iodouracil (FIAU) and killed 24 hr later. DWBA was performed by using previously described methods (14) . Coronal whole body mouse sections (45 m thick) were exposed for 7 days and then developed on a Fuji BAS 5000 Imager at 100-m spatial resolution.
Immunohistochemistry. Tumors were harvested and fixed in 4% paraformaldehyde͞PBS, protected in sucrose, and embedded in OCT medium. Cryostat sections (5 m) were fixed with acetone and blocked with 0.3% H 2 O 2 ͞PBS followed by 5% normal goat serum. Antibody (␣-CD3 or control, 6 g͞ml, PharMingen) was added overnight at 4°C, followed by incubation for 1 hr with goat ␣-hamster IgG conjugated with horseradish peroxidase (room temperature, 1:500, Jackson ImmunoResearch). Reactions were developed with diaminobenzidine. Sections were counterstained with hematoxylin and mounted.
Results

M-MSV͞M-MuLV-Induced Tumors Are Highly Immunogenic and Are
Rejected by Immunocompetent Mice. BALB͞c mice injected intramuscularly with the M-MSV͞M-MuLV complex develop Ͼ1-cm 3 tumors by day 10 after virus challenge (11) . A strong CD8 ϩ cytolytic T cell response against M-MSV͞M-MuLV antigens causes rejection of the tumor by 15-17 days after antigenic challenge. One hundred percent of BALB͞c mice reject the tumor and so provide a reliable source of antigen-specific immune T lymphocytes (ref. 9 , and data not shown).
Introduction of the PET Reporter Gene by Retroviral Infection. Efficient transfer and expression of the PET reporter gene into the target cell is critical to the success of this method. We introduced the HSV1-sr39TK PET reporter gene into primary splenic T cells by retroviral infection, using a bicistronic MSCV retrovirus carrying the reporter gene in the upstream position, and GFP downstream of an encephalomyocarditis virus IRES (Fig. 1A) . HSV1-sr39TK, a mutant of HSV1 TK, displays higher affinity for radioactive acycloguanosines and their derivatives compared with wild-type HSV1 TK (12) . Splenic T lymphocytes were harvested from female BALB͞c mice 3-5 weeks after tumor rejection, when memory T cells are present in the spleen. Because retroviral integration is dependent on cell division (15), purified T cells were stimulated with ␣-CD3 and ␣-CD28, (Fig. 1B) (16) , resulting in infection of Ϸ30-50% of the T cells. Flow cytometry analysis showed that the infected population consisted of both CD8
T Cell Localization to the Antigen-Positive Tumor Requires Preimmunization. We predicted that prior exposure to the antigen was required for T cell migration to the tumor site, and that adoptively CD8-depleted unmarked splenocytes from the same group of immune animals as above were also injected i.p. as a source of help. No recombinant cytokine was provided.
The tumor-bearing animals were imaged several times from day 3 to day 10 after T cell transfer (Fig. 2) . Accumulated data were reconstructed (17) and analyzed. The three-dimensional image was divided into 64 coronal (cross-sectional) planes. The images presented are an average of five consecutive planes that showed the strongest signal in the region of interest. A statistically significant signal (as compared with background) was detected at the tumor site in animals that received immune T cells (Fig. 2 Upper Right). In contrast, the tumor signal was not significantly different from background in the animal that received naive T cells (Fig. 2 Lower Right). [ 18 F]FDG imaging (5), which detects glucose uptake activity, showed that both tumors were viable, metabolically active, and similar in size (Fig. 2 Left) . Highly metabolic areas in the animal such as the brain are also detected by [ 18 F]FDG imaging. The accumulation of [ 18 F]FHBG increased until day 10 in animals that received immune, but not naive, T cells. At this time, the animals were moribund, and were killed. Ten animals that received immune T cells and five animals that received naive T cells were imaged in five independent experiments on days 10-13. These data show that previously immunized T lymphocytes migrate to the established tumor much faster than naive T lymphocytes, despite the presence of CD4 ϩ T cells that can provide cytokine help. To confirm the location of the signal detected by microPET imaging to the tumor site, digital whole-body autoradiography (DWBA) (14) was performed by using [ 14 C]FIAU as the TK substrate. Because of the longer half-life of the 14 C isotope, the abdominal and bladder background signal is greatly reduced by imaging at delayed times, which allows for better clearance of nonphosphorylated substrate. DWBA has a spatial resolution of Ϸ100 3 m 3 , in contrast to microPET (Ϸ8 mm 3 ) (14), providing greater discrimination.
MicroPET imaging using [ 18 F]FHBG on day 12 after T cell transfer detected a significant and specific signal at the tumor site in an animal that received immune T cells (Fig. 3 Left) . Crosssectional whole-body autoradiographic sections of the animal detected a signal in the tumor (Fig. 3 Right) . A digital picture of the section (Fig. 3 Center) provided anatomic registration of the autoradiographic signal at the tumor.
MicroPET data provides a three-dimensional tomographic image, allowing digital reconstruction of the distribution of marked T cells. Thus, differences in signal intensity within a tissue of interest can be determined. Fig. 4 shows images of an animal that bore an M-MSV͞M-MuLV-induced tumor and received HSV1-sr39TK-marked immune T cells. Fig. 4 Upper shows five consecutive planes in the middle of the tumor, of an [ 18 F]FHBG image on day 5 after T cell transfer. The magnitude of the signal is slightly decreased A significant signal was visible at the site of the M-MSV͞M-MuLV-induced tumor on day 4 after T cell transfer (data not shown), and the signal was much higher by day 13 (Fig. 5) . In contrast, the control P815 tumor was not significantly different from background, whether it was present in the same animal (Fig.  5 ) or in a different animal (data not shown). These data demonstrate that adoptively transferred immune T cells rapidly and preferentially localize to the antigen-positive tumor.
Visual determination of the magnitude of signal is a qualitative assessment. A strong advantage of PET is the ability to calculate the amount of radioactivity specifically sequestered in a region of interest (ROI), allowing quantitative determinations of differences in signal intensity. The amount of signal at the tumor site was determined by selecting the part of the image encompassing the tumor, and calculating the proportion of radioactivity present there compared with the total amount injected into the animal. ROIs were drawn over the tumor on decay-corrected whole-body coronal (cross-sectional) images, and percent injected dose (ID) per gram of tissue (% ID͞g tissue) was calculated as described (19) .
The ID͞g of tissue accumulated at the M-MSV͞M-MuLV tumor in animals that received immune T cells was 2.0 Ϯ 1.25% (Table 1) . In contrast, one-fourth as much radioactivity accumulated at the tumor in naive T cell recipients (0.57 Ϯ 0.17% ID͞g) or animals bearing the P815 tumor (P Ͻ 0.05). The control animals were killed earlier because they usually became moribund much sooner because of the tumor burden. Therefore, a smaller number of animals bearing the control tumor or receiving naive T cells were imaged between days 10 and 13.
␣-CD3 Staining of Tumor Sections Detects T Cells Only in the Antigen-
Positive Tumor. To determine whether the greater microPET signal correlated with a larger number of immune T cells at the tumor site, tumors were harvested at the end of the experiment, and sections were stained with ␣-CD3 (Fig. 6) . Counting of positive cells in five fields (ϫ100 objective) showed 20-fold more T cells in the animals injected with immune T cells compared with the animals injected with naive T cells ( Table 2 ) and 10-fold more T cells present in the antigen-positive versus the antigen-negative tumor (Table 2) , confirming the results of the microPET analysis.
The 10-to 20-fold greater numbers of T cells detected by immunohistochemistry, compared with the 4-fold greater signal detected by microPET imaging, probably reflects the localization to the tumor of unmarked immune splenocytes that were introduced into the animal as a source of help.
Discussion
The trafficking of murine antigen-specific T lymphocytes in vivo has been studied by invasive methods, such as injection and recovery of radiolabeled T cells, and intravital fluorescence microscopy (20) (21) (22) (23) . These methods require the use of multiple animals to accumulate data at several time points, and provide limited three-dimensional information.
Several noninvasive imaging methods are currently in use. Optical imaging using the cooled charge coupled-device (CCD) camera (24-26) provides two-dimensional images by detection of fluorescence and bioluminescence. This method has recently been used to detect T cells in an experimental model of autoimmunity (27) . The optical signal is attenuated by body mass, hemoglobin levels, skin and hair, limiting quantitative analysis of the visible signal. Signal emitted from tissues Ͼ1-2 cm beneath the surface cannot be discerned, making quantitation difficult.
The greatest degree of sensitivity and resolution at all depths is provided by radioisotopic imaging methods that provide three- dimensional tomographic information. Single-photon emission computed tomography (SPECT) detects ␥-emitting radioisotopes (28, 29) . PET detects positron emitters, has 10-to 100-fold more detection sensitivity than SPECT, and offers better spatial resolution (30) .
We demonstrate that spatial and kinetic information on the homing and expansion of an immune response can be obtained by using PET imaging. We studied the localization of lymphocytes that had previously seen the tumor antigen because this resembles the situation in a tumor-bearing animal (31) . The expansion of immune T lymphocytes at the antigen-positive tumor was detected as an increased microPET signal, corroborated by an increased percent ID of radioactivity per gram of tissue and greater numbers of T cells detected by ␣-CD3 staining of tumor sections.
Our experiments were conducted in immunodeficient mice and it is possible that in immunocompetent mice T cell localization to the tumor site may display different kinetics and͞or strength of signal. Our method can assess whether immunomodulatory agents that potentiate the activity of T cells, such as ␣-CTLA-4 antibody (32), or their migration, such as IFN-␥ (33), will lead to a change in signal intensity detectable by microPET imaging. The ability to rapidly and noninvasively follow the results of modulating the immune system will allow for the design of more effective clinical studies (34) designed to achieve tumor rejection.
Limiting dilution analysis of M-MSV͞M-MuLV immune T cells showed that Ϸ1 in 2,000 of the transferred immune CD8 ϩ T cells are specific for the viral antigens (8) . The remaining transferred cells travel through the circulation and may settle in lymphoid organs such as the spleen. The lack of a specific signal from the spleen or lymph nodes could be attributed to high background attributable to tracer clearance, the position of the spleen in the abdomen, or insufficient numbers of TK-marked cells within the organs.
Cellular immunotherapy using in vitro cultured tumor infiltrating lymphocytes or allogeneic bone marrow transplantation is currently in use for the treatment of human cancers such as leukemia, renal cell carcinoma, and melanoma (35) (36) (37) and would greatly benefit from the use of PET imaging to study the factors that determine the localization of these cells to the tumor site. This technique can be adapted to use in humans. The source of T cells could be peripheral blood instead of splenic lymphocytes. Infection of human lymphocytes will necessitate use of different viral coat proteins resulting in retroviruses with broader host range. Human T lymphocytes and bone marrow cells can be efficiently infected with retroviruses (38) . The safety and lack of toxicity of [ 18 F]FHBG has been tested in human volunteers, and thus this compound can be used repeatedly in the same patient (39) . PET reporter gene evaluation of T cell responses should have broad applicability to the study of microbial pathogens and autoimmunity as well as tumor immunotherapy.
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